70%Confidence
0Views
SEC EDGARSource
2026-04-21Date
Summary
Prelude Therapeutics Inc (PRLD) has filed an 8-K, indicating a material corporate event or financial disclosure. This filing may signal upcoming news on clinical trials, partnerships, or financial results that could impact its stock volatility.
Actionable: Monitor the 8-K filing details for specific material events affecting PRLD's business outlook.
AI Confidence: 70%
Data Points
companyPrelude Therapeutics Inc (PRLD) (CIK 0001678660)
form8-K
date2026-04-21
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now